Most interestingly, this effect is mediated via the S1PR4 subtype. As peritoneal B cells are the major source of natural serum immunoglobulin (Ig) A, downregulation of S1PR4 reduces the production of intestinal IgA [8] . A critical role of S1PR4 has been detected in mast cells. Olivera et al. were able to show that, although the S1PR4 is dispensable for mast cell degranulation and cytokine production, this receptor subtype regulates passive systemic anaphylaxis in mice [9] .
Bioactive sphingolipids have emerged as key players in cancer cell biology even in a divergent manner. Ceramides have been found to inhibit cancer cell proliferation and to promote cancer cell apoptosis; S1P has been attributed to cell growth and cell survival. Growing evidence has demonstrated that sphingosine kinase (SphK) and S1P signaling are dysregulated in cancers, such as colorectal cancer [10] and glioblastoma multiforme [11] . The relevance of aberrant dicing and splicing of SphK isozymes and the production of variant SphK isoforms in the development and progression of malignancy were discussed by Haddadi et al. [12] . SphK/S1P signaling could be a useful target in the therapy of several cancer types. 1,2,3-triazole-based SphK inhibitors were developed by Severino et al. [13] .
Convincing data indicate a role for sphingolipids in modulating metabolic functions, and changes in levels of specific sphingolipid species have been implicated in metabolic disorders. Thus, the role of S1P in liver diseases, such as hepatic insulin resistance or fibrosis, was reviewed [14] . However, it is of interest that apolipoprotein M (apoM) acts as a chaperone to transport S1P. The role of apoM in liver fibrosis was illuminated [15] . Kidney-derived apoM seems to play an essential role in S1P recovery to prevent urinal loss. The kidney is an organ sensitive to sphingolipid alterations, which may contribute to numerous nephropathic complications [16] . S1P was discussed as a crucial molecule to initiate renal fibrosis. The S1P transporter spinster homology protein 2 seems to be involved in this pathophysiological condition [17] .
As alterations in sphingolipid levels contribute to the initiation and progression of several diseases, it is not astonishing that sphingolipids may serve as biomarkers that identify dysfunction of physiological processes [18, 19] .
Moreover, it is well established that intensive crosstalk occurs between sphingolipids and other lipid classes. Bernacchioni et al. described a novel interaction between ceramide 1-phosphate and lysophosphatidic acid in skeletal muscle, implying a synergistic role of both lipids in muscle regeneration [20] .
In addition to the above-mentioned topics, the special issue includes further distinguished reviews and articles that illuminate the role of sphingolipids in organs and tissues, such as the lung, the skin, the muscle, and the retina. Taken together, this special issue provides new insights into the role of sphingolipid metabolism in health and disease.
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